Mounjaro

What is Mounjaro?

Mounjaro Kwikepin (Tirezaptide) is the newest injectable prescription medication which can be used for weight loss and diabetes management. It works by reducing appetite, making one feel full longer and also regulating blood sugar levels. 

You can now order weight loss injections Mounjaro online from Meds For Less easily, conveniently and reliably to your home address for next day delivery.

Mounjaro KwikPen (tirzepatide) is an injectable prescriptiom medication used for weight loss and diabetes control. It works by mimicking two hormones in the body, GLP-1 and GIP and has the mechanisms of better blood sugar control and better appetite control (by making you feel full for longer). 

Mounjaro injection can be taken once a week in the abdomen, thigh or upper arm. 

The dosage will be tailored to your individual sugar control/weight loss need and can be decided between yourself and your healthcare provider. Usually Mounjaro doses are started low and then increased gradually to help the body tolerate the effects. 

How does it work?

The Mounjaro medication contains the active ingredient Tirzepatide and belongs to a new class of drugs which mimic both GLP-1 and GIP hormones in the body.

Mimicking these hormones blood sugar regulation and weight loss occurs in the following ways:

• Increasing insulin secretion by the pancreas when glucose levels are high allowing for more stable glucose levels overall.
• Suppressing unnecessary blood glucose release into the bloodstream by the liver by suppressing the hormone glucagon.
• Helps weight loss by delaying emptying of the stomach and creating a lasting sense of fullness, thereby reducing the urge to eat more.
• Acts on appetite centers in the brain to reduce hunger and food intake, further helping weight loss.

Mounjaro is unique in it’s dual action, containing both GIP and GLP-1 mimetic. In contrast to previous GLP-1 only mimetics, Mounjaro has an enhanced action profile when it comes to weight loss and blood sugar control.

For whom is it suitable?

Mounjaro is recommended for patients with obesity (Having a BMI > 30) or for Overweight patients (BMI > 27) who have weight related health concerns such as type 2 diabetes, hypertension or high cholesterol.

How effective is Mounjaro?

Mounjaro has shown a high level of effectiveness with blood sugar control in the management of type 2 diabetes and weight loss potential in obesity.

Clinical trials have shown that Mounjaro can reduce HbA1c levels (a marker for diabetes) from 2.1% to 2.4% over the period of 9 months to a year. Over 90% of people who used Mounjaro achieved a reduction of Hba1c down to 7%, (the typical target for diabetes management). This was shown to be more than that achieved by other treatments such as Ozempic or Insulin.

Clinical trials have also shown that Mounjaro is very effective for weight loss. Mounjaro weight loss has shown to be more effective than previous weight loss medications such as Wegovy, achieving up to 22.5% weight loss over 72 weeks when combined with diet restrictions and exercise.

This high degree of effectiveness of the Mounjaro injection for weight loss can be attributed to it’s dual action as both a GLP-1 and a GIP mimetic and has been described as a “game changer “ for obesity and diabetes management.

Dosage

Mounjaro can be administered via a subcutaneous injection once a week. Dosages are started low and increased gradually over time to help the body get used to the effects of the medicine.

Mounjaro is initially started at a dose 2.5 mg once weekly for the first 4 weeks and then gradually to a maintenance dose of 5mg once weekly. If additional dosage is required, the dose may be increased further to:

• 7.5 mg once weekly
• 10mg once weekly
• 12.5mg once weekly
• 15mg once weekly (the maximum possible dose)

Please consult your healthcare provider about what the right dose of Mounjaro (Tirzaeptide) is for you and your health purposes. 

Alternatives

There are several alternative treatments to Mounjaro that you can use for diabetes management, weight loss or both.

Alternative diabetes treatments include:

• Other GLP-1 mimetics such as Rybelsus (Oral semaglutide), Ozempic (injectable semaglutide) and Saxenda (injectable liraglutide).
• Sulfonylurea class of diabetes medications (such as Glicazides)
• SGLT-2 inhibitor class of diabetes medications (such as Invokana)

Alternatives for weight management include:

• Wegovy , a higher dose of semaglutide meant for obesity treatment
• Saxenda, an injection of liraglutide meant for obesity treatment
• Orlistat, an oral medicine which reduces fat absorption from the intestines

Please speak to your healthcare provider about the appropriate medicine for your diabetes or weight management. 

Side effects

Like most medications, Mounjaro has side effects which can range from mild to serious. 

Common side effects are often milder and occur around the time medication is started or doses are changed, whereas rare side effects are often more serious.

Common side effects include:

• Nausea
• Vomiting
• Diarrhoea
• Vomiting
• Abdominal discomfort
• Fatigue

Rarer but more serious side effects include:

• Gallbladder issues leading to jaundice
• Pancreatitis which can cause severe abdominal pain, nausea and back pain
• Severe allergic reactions such as rash, swelling of mouth or lips and difficulty breathing

If you experience any of the symptoms of these rare but more serious side effects, please seek medical attention immediately.